Taylor, P A; Miles, E; Hoffmann, L; Kelly, S M; Kry, S F; Moller, D S; Palmans, H; Akbarov, K; Aznar, M C; Clemantel, E; Corning, C; Effeney, R; Healy, B; Moore, A; Nakamura, M; Petel, S; Shaw, M; Stock, M; Lehmann, J; Clark, C H (2023) Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiotherapy and Oncology, 182. 109494

Kry, S F; Lye, J; Clark, C H; Andratschke, N; Dimitiadis, A; Followill, D; Howell, R; Hussein, M; Ishikawa, M; Kito, S; Kron, T; Lee, J; Michalski, J; Monti, A F; Reynaert, N; Taylor, P; Venables, K; Xiao, Y; Lehmann, J (2021) Report dose-to-medium in clinical trials where available; a consensus from the Global Harmonisation Group to maximize consistency. Radiotherapy and Oncology, 159. pp. 106-111.

Mir, R; Kelly, S M; Xiao, Y; Moore, A; Clark, C H; Clementel, E; Corning, C; Ebert, M; Hoskin, P; Hurkmans, C W; Ishikura, S; Kristensen, I; Kry, S F; Lehmann, J; Michalski, J M; Monti, A F; Nakamura, M; Thompson, K; Yang, H; Zubizarreta, E; Andratschke, N; Miles, E (2020) Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. Radiotherapy and Oncology, 150. pp. 30-39. ISSN 01678140

Clark, C H; Hurkmans, C W; Kry, S F (2017) The role of dosimetry audit in lung SBRT multi-centre clinical trials. Physica Medica - European Journal of Medical Physics, 44. pp. 171-176.